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 ABSTRACT: Cyclodextrins are enabling pharmaceutical excipients that can be found 
in numerous pharmaceutical products world-wide. Due to their favorable toxicological 
profiles cyclodextrins are often used in toxicological and Phase I assessments of new 
drug candidates. However, at relatively high concentrations cyclodextrins can 
spontaneously self-assemble to form visible microparticles in aqueous mediums and 
formation of such visible particles may cause product rejections. Formation of sub-
visible cyclodextrin aggregates are also known to affect analytical results during 
product development. How and why these cyclodextrin aggregates form is largely 
unknown and factors contributing to their formation are still not elucidated. The 
physiochemical properties of cyclodextrins are very different from simple amphiphiles 
and lipophilic molecules that are known to self-assemble and form aggregates in 
aqueous solutions but very similar to those of linear oligosaccharides. In general, 
negligible amounts of aggregates are formed in pure cyclodextrin solutions but the 
aggregate formation is greatly enhanced upon inclusion complex formation and the 
extent of aggregation increases with increasing cyclodextrin concentration. The 
diameter of the aggregates formed is frequently less than about 300 nm but visible 
aggregates can also be formed under certain conditions. 
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 Dr. Marcus Brewster 
With this review paper, we would like to honor our esteemed and deeply respected 
colleague Dr. Marcus Brewster. He was Vice President and Scientific Fellow of the 
Pharmaceutical Development and Manufacturing Sciences group at Janssen 
Pharmaceutica R&D. 
Dr. Marcus Brewster contributed to the development of several important medicines that 
are benefitting patients today. He was a major advocate for the use of cyclodextrins 
(CDs) in drug formulations and his contributions created the foundation for the regulatory 
approval and marketing of 2-hydroxypropyl-β-cyclodextrin (HPβCD)-based formulations 
worldwide including both oral and intravenous based dosage forms of itraconazole 
(Sporanox®). Thanks to his work, CDs are now routinely used in toxicological and Phase 
I assessments of new drug candidates. 
The discovery of the self-association behavior of both CDs and certain drug-CD 
complexes sparked the interest of Dr. Marcus Brewster and it quickly became one of his 
favorite research topics. For a number of years we enjoyed collaborating with him on this 
subject. We had submitted a grant application to study self-assemble of CDs and CD 
complexes, and its impact on CD research and applications. It took couple of years but 
few months before his death we received a very generous grant to study “drug-CD 
aggregates in formulation assessment and drug delivery”. The subject of the grant 
originated from an observation of visible microparticles in parenteral solutions containing 
relative high CD concentrations. The formation of such visible and sub-visible CD 
aggregates may cause rejections and even product withdrawal. On the other hand, 
these interesting constructs can also be looked at as a starting point for a new breed of 
drug delivery vectors. These structures seem to form under certain conditions but are 
less common in other environments. 
Drug-CD constructs hold the promise of formulating difficult-to-formulate drugs as well 
as specifically targeting their delivery topically, orally as well as parenterally. Initial 
studies have demonstrated that topical assessment of these systems to the skin resulted 
in targeted drug delivery to the hair follicles and sweat glands. In addition, work in 
modified Caco-2 cell cultures (e.g., mucus-producing systems) and other models have 
suggested that CD aggregates may act as mucus-penetrating delivery vectors that can 
 rapidly translocate drugs from the intestinal lumen to the absorptive epithelium. This 
effect has been reported to be enhanced by nanoparticles with hydrophilic coronas that 
minimize protein interaction. 
How and why these aggregate systems form is largely unknown and factors contributing 
to their robustness are still not elucidated. The aggregation phenomena in CD solutions 
have been for a long time ignored by academic and industrial scientists. Only during the 
last decade several research groups in the world started to focus on this problem. This 
article describes in more detail the observations that lead to this grant application.  
 
Introduction 
Some water-soluble solute molecules spontaneously self-assemble in aqueous solutions 
to form aggregates.1 Depending on the molecular structure and solvent properties, the 
aggregates may take a shape of rods, discs, prolate spheroids, spheres, bilayers, 
vesicles or reversible micelles.2,3 At concentrations exceeding the critical aggregation 
concentration (CAC) a high degree of association may even lead to formation of 
lyotropic mesomorphs, e.g. lamellar, hexagonal, cubic and ribbon phases.4-6 The self-
assembly properties of substances can be used to develop novel pharmaceutical 
formulations. Different types of aggregates may be developed into drug delivery systems 
like micelles, nanoparticles, microspheres, liposomes and hydrogels to overcome 
formulation challenges, such as poor aqueous drug solubility, drug permeation through 
mucus and membrane barriers, and inadequate drug stability, as well as to enhance 
biological properties of drugs such as to reduce or prevent their side effects.7-10 
Application of molecular self-assemble in pharmaceutical technology and other sciences 
will however require thorough understanding of the thermodynamics and kinetics 
involved. 
Surfactants and other amphiphiles, that have both hydrophilic and hydrophobic sections 
in their structure, are known to self-assemble in aqueous solutions to form micelles with 
a hydrophobic core and hydrophilic outer shell. Full understanding of the micelle 
formation and the forces involved (e.g., van der Waals, electrostatic and hydrophobic 
interactions, hydrogen and coordination bonds) is, however, still lacking.1 Micelle 
formation is a thermodynamically favored process. The attraction of hydrophobic 
 species, resulting from their avoidance of water molecules in aqueous solutions, 
represents the hydrophobic interaction (i.e. formation of hydrophobic bonds). This 
interaction is favored thermodynamically because it minimizes the contact surface 
between water molecules and the non-polar group of an amphiphile with a consequent 
entropy increase (Fig. 1). The entropy increase (ΔS) upon micellization is partly due to 
increased flexibility of the hydrocarbon chains (on their transfer from an aqueous 
environment to the hydrophobic micellar core) and partly due to release of water 
molecules during neutralization of the ionic charge by the counterions (in case of ionic 
and zwitterionic surfactants).11 Furthermore, there is an additional enthalpic contribution 
(ΔH) associated with the van der Waals interactions between hydrocarbon chains as 
well as between the hydrophilic head groups and the surrounding water molecules. 
For many non-ionic micelles, the numerical values of the enthalpic contribution to the 
Gibbs energy of micelle formation (ΔG = ΔH – TΔS) is of the order of 10 kJ per mole, 
while the entropic term (TΔS) can have a value of about 40 kJ per mole.12 Consequently 
some researchers have emphasized the significance of the entropic effect and 
hydrophobic interactions in the process of micelle formation.13 Significance of the 
entropic components has been traced in atomistic simulations studies of the self-
assemble of non-ionic chromonic molecules.14 The calculations have showed that the 
numerical value of the entropic term is 1.5 times higher than that of the enthalpic one. 
Other researchers have studied thermodynamic properties of micellization of zwitterionic 
surfactants through molecular dynamics simulations and found that the aggregation 
process is entropy-driven and enthalpy–entropy compensated with increasing 
contribution of the enthalpy-driven part.15,16 Based on an isothermal titration calorimetry 
study of homologous series of sulfobetaines (a form of zwitterionic surfactants), it was 
shown that the thermodynamics of micellization is mainly entropically driven at low 
temperatures but by both enthalpy and entropy at elevated temperatures. Such 
exchanging in dominant terms (from entropic to enthalpic) has been explained as 
reduction of water cohesion (or hydration ability) at elevated temperatures accompanied 
by consequent reduction of the hydrophobic effect.13,17 Indeed, the free energy of 
aggregation involves significant changes in repulsive and attractive contributions of the 
 various interactions between hydrocarbon chains, head groups and solvent molecules. 
These interactions are equilibrium processes that occur on a microsecond timescale. 
Self-assemble of solute molecules in aqueous solutions is affected by both internal and 
external factors. Internal factors include only native properties of the self-associated 
molecules while the external ones depend on environmental condition of the aqueous 
media such as temperature and ionic strength. Influence of the molecular structure and 
their physicochemical properties can easily be estimated from the numerous theoretical 
works. Some quantitative structure–activity relationship (QSAR) efforts describing the 
critical micelle concentration (CMC) are highlighted in a publication by Messina et al.18 
Frequently, the main descriptors are or depend on the size and surface area of the 
hydrophobic and hydrophilic moieties as well as on numerous other molecular properties 
such as the structural complexity of the hydrophobic moiety, van der Waals volume of 
the molecule, molecular flexibility, dipole moment of the molecule, relative positive 
charge and partial positive surface area of the hydrophobic domain, heat of formation 
and the octanol-water partition coefficient. For example, increased chain length of a 
hydrophobic moiety usually decreases the CMC value.19-21 On the contrary, increasing 
the number of ionic head groups, or the charge of an ionic head group, will cause 
increase of electrostatic repulsion between them. That is why substances with ionic 
head groups (i.e. hydrophilic moieties) have higher CMC values than those containing 
non-ionic ones. Repulsive forces also define the size of micelles.22 If the repulsive forces 
are strong the micelle size becomes small but it can become very large when the 
repulsive forces are weak as in the case of nonionic surfactants. Regarding external 
factors, increase of medium ionic strength will reduce solute hydration, decrease 
electrostatic repulsion and increase counterion binding that ultimately will decrease the 
CMC.18,23 Changing of ionic strength is more effective for ionic substances than non-
ionic ones. Influence of temperature on aggregation process is however not so 
ambiguous. Temperature dependencies of the CMC are frequently not linear but have 
U-shape.19,20 The U-shape relationship is the product of two opposing effects observed 
during the temperature increasing, that is the decreasing in the hydration of the head 
groups and disordering of structured water surrounding the hydrophobic moieties. For 
 ionic surfactants the cohesion between the molecules becomes more difficult with 
increasing temperature and hence CMC increases. 
The physicochemical properties of water 
Understanding of solute self-assemble in aqueous solutions requires some 
understanding of the physicochemical properties of water and the solute-water 
interactions. Although the structure of liquid water appears to be trivial, consisting of two 
hydrogen atoms forming covalent bonds with one oxygen atom, its physicochemical 
properties are very unique.24-27 The electrostatic surface of water is characterized by the 
difference in electronegativity of the hydrogen and oxygen atoms, 2.20 and 3.44, 
respectively, by the Pauling scale. Thus, the water molecule is a dipole with a partly 
negative oxygen atom and two partly positive hydrogen atoms. The result is electrostatic 
attraction between hydrogen atoms of one water molecule and the oxygen atoms of 
nearby water molecules, that is, to formation of H-bonds (i.e., hydrogen bonds) between 
neighboring water molecules. In liquid water the bond energy of the covalent H-O bonds 
is 492 kJ per mole while the bond energy of the intermolecular H-bonds is much lower or 
about 23 kJ per mole.24 Traditional concepts of the structure of liquid water imply the 
presence of a complex hydrogen bond networks, where one molecule of water can have 
up to 4 hydrogen bonds (Fig. 2). However, recent studies show that at room temperature 
about 80% of water molecules make one strong H-bond and, by symmetry, accept one 
H-bond for a total of two H-bonds per water molecule. Furthermore, due to their 
relatively low activation energy the H-bonds in liquid water are constantly switching 
partners forming networks of water chains and rings that are continuously being formed 
and dissembled on the femtosecond (i.e., 10-15 of a second) timescale in weakly 
hydrogen-bonded disordered network.28,29 Consequently, water behaves like a polymer 
((H2O)n) of a number (n) of monomeric water units (H2O) with a boiling point that is about 
200°C higher than expected based on the boiling points of other group VI hydrides of the 
periodic table.27 Although water and clear aqueous solutions appear homogeneous they 
are heterogeneous where solvent and solute clusters are constantly being formed and 
dissembled.30 Solute molecules do affect hydrogen bonding of water. 
 
Hydration and self-assemble of carbohydrates 
 Carbohydrates represent the most abundant class of organic compounds and play a 
fundamental role in many biological processes. Due to their physicochemical, structural 
and favorable toxicologic properties carbohydrates are commonly used as excipients in 
pharmaceutical, food and cosmetic products. Thus, aqueous carbohydrate solutions are 
of interest to pharmaceutical scientists as well as the interaction of carbohydrates with 
other solute and solvent molecules. Carbohydrates are organic compounds that have 
the highest number of hydroxyl groups per molecule and these hydroxyl groups can both 
serve as H-bond acceptors and H-bond donors. Molecular dynamics simulations have 
shown that the H-bonding abilities of glucose in aqueous solutions is both concentration 
and temperature dependent.31 It is thought that at low concentrations glucose molecules 
are more efficient H-bond acceptors while at high concentration they are more efficient 
H-bond donors. 
The ability to form H-bonds significantly affects the interaction between carbohydrate 
molecules such as sugars and between carbohydrate molecules and their hydration 
shell.32-35 Hydration of sugars has recently been studied by both simulation (i.e. in 
silico)32,36-38 and experimental39-42 techniques. When monosaccharides and 
oligosaccharides are dissolved in water each OH group forms a H-bond with 
approximately three water molecules although the number of bound water molecules 
decreases somewhat with increasing molecular weight (Mw). Hence, in dilute aqueous 
solutions one glucose molecules binds 14 water molecules while maltodextrin molecule, 
containing on the average 6.2 glucose units, binds 50 water molecules or about 8 for 
each glucose unit.39 It has been estimated that each glucose unit of α-cyclodextrin 
(αCD) and γ-cyclodextrin (γCD), formed by 6 and 8 glucose units, respectively, binds 
about 6 water molecules in aqueous solutions at 25°C.43 However, the hydration value 
(i.e., the number of bound water molecules) does depend on the method applied and 
this observed variation in the hydration value is frequently explained by specific 
interactions of solute molecules due to sharing of hydration shells.36 In other words, the 
tendency of sugars and other carbohydrates to aggregation even at low concentrations 
leads to increasing of the so-called hydration-water-sharing phenomenon (Fig. 3). 
Binding of water molecules decreases their mobility that leads to increased media 
viscosity with increasing sugars concentration. At low sugar concentrations the mobility 
 of water molecules decreases (i.e., the solution viscosity increases) linearly with 
increasing sugar concentration but then the viscosity increases more rapidly with 
positive deviation from linearity as the sugar concentration increases due to overlapping 
of the hydration shells and cluster formation.36,44 CDs appear to display similar behavior 
(Fig. 4). Studies of aqueous sugar solutions have shown how sugar molecules influence 
the arrangement of water molecules.45-47 At lower concentrations they behave as a 
water structure breakers, while at higher concentrations they act as a structure makers. 
In fact, studies indicate that increasing sugar concentrations lead to overall increase in 
number of H-bonds between sugar molecules and water, as well as to increased water-
water H-bond lifetimes and the associated activation energies with a consequent 
viscosity increase.48-50 
Frequently the tendency of sugar molecules to aggregate is associated with their ability 
to form intermolecular H-bonds.40,42,51 Glucose, trehalose, maltodextrin and other 
carbohydrates are known to self-associate in aqueous solutions and undergo 
concentration-dependent clustering.32,44,52-54 For example, a recent study of sugar 
solutions by dynamic light scattering (DLS) revealed power law growth of glucose, 
maltose and sucrose clusters as a function of sugar concentration.53 Due to strong 
intermolecular H-bonding such clusters can be stable at temperatures as high as 
90°C.53,55 Simulations have shown that trehalose molecules form clusters in aqueous 
solutions and that their sizes increase with increasing trehalose concentration (Fig. 5) 
with a percolation concentration (i.e. the concentration at which continuous three-
dimensional trehalose lattice is formed) of about 70% (w/v).51 Small clusters are formed 
at low trehalose concentrations (i.e. less than 1% w/v) and these small clusters are 
short-lived on the picosecond scale, constantly being formed and dissembled.40 
Aminocellulose (Mw 3250 Da) has been shown to form fully reversible tetramers in 
aqueous solutions through H-bonding and that these tetramers associate further in a 
step-wise fashion into higher order structures.56 Indeed, with increasing sugar 
concentrations the average number of H-bonds between individual sugar molecules 
increases until continuous H-bonded carbohydrate networks are formed in the aqueous 
media.51,53,54 The observed differences in aggregation behavior of the various sugars, 
such as sucrose, maltose and trehalose, can be explained by their structural differences 
 and their abilities to form intra- and intermolecular H-bonds.37,42,48 Topological (i.e. three-
dimensional structural) differences of these molecules and their ability to form intra- and 
intermolecular H-bonds determines their ability to aggregate and the size of the 
aggregate clusters formed as well as their influence on the dynamics of water molecules 
of the hydration shell. 
 
Self-assemble (aggregation) of cyclodextrins 
The four main chemical groups of carbohydrates (synonym: saccharides) are 
monosaccharides, disaccharides, oligosaccharides (typically formed by 3 to 9 
monosaccharides) and polysaccharides. CDs form a subgroup of oligosaccharides that 
were discovered over 120 years ago by Antoine Villiers (1854-1932) during his study of 
enzymatic degradation of carbohydrates.57-59 In the following decades the cyclic 
structure and chemistry of CDs was revealed and shown that CDs consist of several 
α(1→4) linked D-glucopyranose units (Table 1).60,61 The arrangement of hydroxyl groups 
on the doughnut-shaped CD molecules bestows hydrophilic and hydrophobic domains 
on them: a polar exterior and a non-polar interior. While their polar exterior allows for 
solvation of CDs in aqueous solutions their central cavity enable encapsulation of non-
polar molecules or molecular moieties, a property that has been explored in 
supramolecular,62-66 analytical,67-71 food72-75 and pharmaceutical76-81 chemistry. 
The structure and physicochemical properties of CDs (Table 1) are similar to those of 
other oligosaccharides but very different from the previously mentioned simple 
amphiphiles and hydrophobic drugs (Fig. 1). CDs are carbohydrates and do self-
assemble like other carbohydrates. The best known example of such self-assemble in 
aqueous solution is probably opalescence of aqueous γCD solutions followed by γCD 
precipitation that occurs even at low γCD concentrations. This has hampered the usage 
of γCD in pharmaceutical products such as parenteral solutions. Szente and his 
coworkers tried to explain and prevent this γCD aggregation.82 Their conclusion was that 
the only practical way to prevent opalescence of aqueous γCD solutions was through 
chemical modifications of the γCD molecule. During studies of aqueous CD solutions, 
even aqueous solutions of some of the very water-soluble CD derivatives, investigators 
frequently noted that their behavior did not follow accepted theoretical equations and 
 sometimes indicated that observed deviations from theoretical equations could be due to 
formation of CD aggregates. For example, Miyajima and coworkers83,84 observed that 
the activity coefficient of aqueous CD solutions decreases with increasing concentration 
of αCD, γCD and dimethyl-βCD, and explained this observation by CD dimerization. 
Self-assemble of CD molecules has also been suggested based on X-ray85-90 and 
scanning tunneling microscopical data,91 as well as by molecular simulation studies.92-94 
A complex concentration and temperature dependency of the activity coefficient of 
aqueous CD solutions was observed by Terdale coworkers and related to both CD–
water and CD–CD interactions.95 Studies indicated that the presence of H-bonded CD 
aggregates in aqueous media and their interactions with water molecules were 
responsible for the unexpected CD behavior.96-99 Numerous studies by our group show 
how micelle-like assembles of dissolved CD molecules and their complexes affect CD 
solubilization of lipophilic drugs in aqueous media and how these assembles hamper 
drug permeation through semi-permeable membranes.100-104 
The growing industrial applications of CDs and improvements in analytical technology 
have sparked interest in self-assembled CD aggregates. Formation of such aggregates 
in aqueous solutions is now generally accepted although there are still some 
disagreements regarding to their size and shapes.105,106 Numerous light scattering 
studies have shown that the parent αCD, βCD and γCD form aggregates in aqueous 
solutions.96,107-110 Some of these results have been summarized and presented as plots 
showing the relationship between the aggregate size and CD concentration (Fig. 6).105 
For known self-assembling compounds like ionic liquids or surfactants, the CAC (or 
CMC for surfactants) is usually determined by measurement of physicochemical 
parameters of their aqueous solutions as function of compound concentration. 
Frequently used methods are tensiometry, conductometry, fluorimetry, light scattering, 
or nuclear magnetic resonance (NMR) spectroscopy.111-117 The common procedure to 
determine the CAC from experimental data is to determine the intersection of two 
straight lines traced through plots of the measured physical property versus the 
concentration. For CDs and CD complexes, there are few publications that describe the 
determination of the CAC. In a study of βCD self-assembly by De Sousa et al., 
scattering intensity was monitored by DLS during titration of βCD into water.118 Two 
 distinct regions were observed when the scattering intensities as a function of βCD 
concentration were plotted. The CAC values of βCD at different temperatures were 
determined and used to calculate the thermodynamic parameters (Gibbs energy, 
enthalpy, entropy) of the formation of βCD aggregation. 
Determination of CAC with different analytical techniques can lead to different values. In 
one study, the chemical shift of the CH3 group of HPβCD was measured from 1H-NMR 
spectra obtained at different concentration ranges.119 In this study, the chemical shifts 
were plotted as a function of the inverse of the total HPβCD concentration. The 
calculated CAC for HPβCD was 77.7 mg/ml. In another study, conductivity was used to 
obtain the CAC value of HPβCD by plotting the conductivity values against the HPβCD 
concentrations in aqueous solution.120 In that case the CAC of HPβCD was determined 
to be 69.3 mg/ml. Similar differences have also been observed during aggregation 
studies of ionic liquids in aqueous media or of CMC of surfactants. The reason for these 
differences in determined CAC values is, first, different techniques measure different 
physicochemical parameters and, second, the CAC is rather a concentration range at 
which the aggregation of free monomers begins rather than one specific concentration 
below which no aggregates can be found and above which one specific type of 
aggregates exists.120,121 
The general trend is that the aggregate size increases with increasing CD concentration. 
Moreover, the aggregates appear at CD concentrations as low as 3-12 mM, that is well 
below the CD solubility of 150 (αCD), 16 (βCD) and 180 (γCD) mM.122 Furthermore, the 
studies show size distribution that can vary from 20 nm to a couple of µm although the 
reported diameter of CD aggregates is most frequently between 90 and 300 nm. The 
kinetics of aggregate formation is not well understood and aggregate size variations 
have been observed, even during repeated size determinations of identical CD solutions 
by identical methodology.82,107 CD molecules may lose hydrogen-bond donors (i.e., OH 
groups) upon derivatization and generally consist of not one molecular structure one but 
of a complex mixture of geometrical and optical isomers and, thus, CD derivatives are 
thought to have less tendency to self-assemble and form aggregates than their parent 
CDs.105,107,108,123 
 The DLS technique, which is frequently used to detect nanoparticles, assumes that the 
self-assembled aggregates have spherical structure while the various microscopic 
methods allow observation of the actual shape of aggregates. Studies of aqueous βCD 
solutions by transmission electron microscopy (TEM) at cryogenic temperature 
confirmed the concentration dependency of the mean aggregate diameter but revealed 
also that the shape of CD aggregates is concentration dependent.109 At βCD 
concentration of 3 mM small (6 nm) globular particles were observed that could interact 
with each other to form branched and discoidal structures with size ranging from 30 to 
100 nm. Increasing the βCD concentration above 6 mM leads to the formation of new 
structures, large (over 500 nm) sheet like domains, which can be transformed to fibers 
and folded lamellae by sonication. Stirring of the aqueous media has been shown to 
affect the shape of the aggregates.124 A Cryo-TEM study of amphiphilic βCD derivatives 
showed spheroidal particles with a diameter of approximately 50 nm.125 Kinetic 
measurements indicated that the nano-spheres formed are stable for at least three 
years. Porous silica material has been prepared using various parent CDs and their 
derivatives as template phases.126 Microscopical studies of the products displayed 
formation of worm-like cavities occupied by supramolecular CD aggregate structures. 
More detailed review of microscopy characterization of CD assembles was published by 
He and coworkers.106 
It is noteworthy that the wide variety of shapes formed by CD aggregates is based on 
only two types of molecular arrangements. If we consider the association processes as 
the nucleation step during crystallization then molecular packing during nucleation and 
crystallization should be identical. Crystal structures of both native CDs and their 
inclusion complexes are either of channel- or cage-type (Fig. 7).89 Rapid recrystallization 
of αCD and γCD results in formation of channel structures.127,128 It was shown that 
induced water sorption-desorption cycle results in phase transformation (from channel to 
cage type) with intermediated amorphous state. After reaching sorption equilibrium, the 
CD molecules undergo a slow rearrangement (duration of about 100 h for αCD and 192 
h for γCD) to the cage structure with defined water content. These observations show 
how important water molecules are and how hydration shell affects the structure of self-
assembled CD molecules, and the structure and dimensions of CD aggregates. 
 The observations and experimental results described above show how complex and 
ambiguous self-assemble of CD molecules and their aggregate formation is. Indeed, 
self-assemble of CD molecules in aqueous solutions to form aggregates and 
disassemble of the CD aggregates formed are in dynamic equilibrium. Moreover, the 
encapsulated water molecules present in the CD cavity and water molecules forming 
their hydrated shell are in dynamic equilibrium with other water molecules in the 
aqueous media on the nanosecond timescale. In turn, every CD molecule has its own 
dynamic behavior caused by rotational freedom of the glucopyranose building blocks 
and the overall molecular mobility. Stabilization of these aggregated systems is 
controlled by specific (van der Waals forces) and non-specific (hydrogen bonds) 
interactions, which are at all times in competition. Although the ability of CDs to self-
assemble to form aggregates is well documented it has also been shown that the 
aggregates are very unstable. Attempts to stabilize nano-size self-assembled CD 
aggregates of the native αCD, βCD and γCD and their hydrophilic (monomeric) 
derivatives have so far not been successful. 
 
Self-assemble of cyclodextrin complexes 
CD inclusion complex is formed when lipophilic molecule (the guest), or more frequently 
some lipophilic moiety of a larger molecule, enters the somewhat hydrophobic central 
cavity of a CD molecule (the host). A number of forces are thought to be involved in the 
inclusion complex formation including van der Waal’s forces, electrostatic interactions, 
formation of H-bonds, release of conformational strain and exclusion of high energy 
water bound in the CD.129-131 The complex formation is almost always associated with a 
relatively large negative ΔH and a ΔS value that can either be positive or negative. In 
addition to inclusion complexes CDs are, like non-cyclic oligosaccharides, also able to 
form non-inclusion complexes where, for instance, the hydroxyl groups on the outer 
surface of the CD molecule form hydrogen bonds with the drug of interest.130 For 
example, using mass spectrometry (MS) it has been shown that αCD forms both 
inclusion and non-inclusion complexes with dicarboxylic acids and that the two types of 
complexes coexist in aqueous solutions. MS allowed selective measurement of CDs as 
well as drug/CD complexes, including their stoichiometry. Distinction between inclusion 
 and non-inclusion complexes was facilitated by comparison with interaction of the drug 
with a linear sugar incapable at making inclusion complexes in solution. This way the 
obtained MS data provided a valuable image of the two types of complexes that coexist 
in aqueous solution.132 
Over the years a wealth of data has been accumulated about CD complexes and their 
physicochemical properties. The complexation changes the physicochemical properties 
of both the guest and the host, and both physicochemical and biological properties of 
drugs can be improved through CD complexation. Numerous research publications and 
reviews have reported how drug solubility,133-138 permeability,26,133,139,140 
bioavailability74,141-144 and chemical stability145-147 can be improved through CD 
complexation. Most often drug/CD complexes are dimer complexes (i.e., formed by one 
drug molecule and one CD molecule) but ternary complexes are also frequently 
described where water-soluble polymers, metal ions or organic salts are used to 
enhance the CD effect.148 It should be emphasized that in aqueous solutions there is a 
constant equilibrium between molecules forming the CD complex and free dissolved 
molecules. Furthermore, more than one type of guest/CD complexes can coexist in 
aqueous solutions. For instance, in aqueous solutions vanillin has been shown to form 
1:1 inclusion complex with βCD but 1:2 vanillin:βCD complexes were also detected.149 In 
multicomponent systems, containing more than one type of guest molecules, 
reorganization of complexes can be initiated by competition among different types of 
guest molecules and in a dynamic system complex composition can change over 
time.150,151 Figure 8 shows a schematic representation of different transformation 
pathway of a drug-CD system. The figure shows that interactions between drug 
molecules and CD molecules are not limited to inclusion complex formation. 
Coexistence of inclusion and non-inclusion complexes in aqueous CD solutions has 
been documented101,102,132,152-155 and there are some indications that formation of such 
non-inclusion complexes can be associated with formation of drug/CD complex 
aggregates.156 In aqueous solutions free CD molecules have some tendency to self-
assemble to form aggregates. However, their tendency to self-assemble increases upon 
formation of inclusion complexes and appears to be proportional to the concentration of 
inclusion complexes in the solution (Fig. 9).157 For example, the asymmetry of Job’s 
 plots obtained by NMR studies of aqueous CD solutions has suggested premicellar 
association of inclusion complexes of a cationic surfactant and βCD followed by micellar 
association of the inclusion complexes.158 Other investigators observed micelle-like 
assembles (micelle structures with diameters more than 200 nm) in aqueous solutions 
containing trans-β-carotene and βCD and γCD.159 Previously we studied the effects of 
CD concentrations on the permeation of hydrocortisone,100,160-162 indomethacin,163 
diclofenac sodium,161,163 amphotericin B,161 irbesartan,164 carvedilol,165 
dexamethasone163,166 and dorzolamide167 through semi-permeable cellophane 
membranes of various molecular weight cut-offs (MWCO). The observed permeation 
profiles displayed negative deviation from the expected linear profiles predicted by Fick's 
first law of diffusion. Formation of drug/CD complex aggregates in the nano-size range 
was confirmed by other techniques such as DLS and TEM, and the observed negative 
deviation from linearity shown to be due to drug/CD complex aggregation. In most cases 
the drug/CD complex aggregation was initiated at CD concentration of about or below 
10% (w/v). Self-association of CD complexes can explain the observed decrease in the 
activity coefficient with increasing of CD concentration,161 and the method dependent 
complex stoichiometry (i.e., the stoichiometry of a given complex depends on the 
method applied).101,104 These observations are summarized in Table 2. 
Amphiphilic CDs have been obtained by chemical modifications of their macrocycles 
using various anchors (e.g. phospholipidyl, cholesteryl and oligo(ethylene oxide) 
groups). Grafting of hydrophobic moieties by reaction with the primary or secondary 
hydroxyl groups confers them an amphiphilic character.168-172 Such amphiphilic 
compounds may self-organize in aqueous phase to form supramolecular assemblies. 
One such example is Chol-DIMEB: this molecule consists of a parent methylated βCD in 
which one of the anhydroglucose units is linked with cholesterol via its primary hydroxyl 
group through a succinic acid spacer. The molecule self-aggregates into micellar 
structures of about 5 nm in diameter with an aggregation number of about 24 and a 
CMC of 5±2·10-6 M, indicating a high associative behavior.169 The micelles form a 
hydrophobic core (the cholesterol moiety) and a polar surface (methylated βCD). 
 
 Effects of derivatization, ions, polymers and other excipients on the complexation 
and aggregation 
Water-soluble polymers and surfactants are known to stabilize various types dispersed 
systems in aqueous solutions.173-176 Similarly, water-soluble polymers, salts and 
surfactants have been shown to have stabilizing effect on CD aggregate and, in some 
cases, to enhance the complexation efficiency and solubility of drug/CD 
complexes.156,177-185 
Substituted CDs have been specifically designed to improve aqueous solubility. These 
CD derivatives often present mixtures of positional and regional isomers with different 
degree of substitution (DS). Interestingly, it has been demonstrated that the DS of CD 
derivatives influences the entropy and enthalpy driven processes which contribute to 
drug inclusion formation, eventually causing changes in the complexation capability of 
CDs. For example, it has been reported that the affinity of different substrates for 
SBEβCD is affected by the DS. Notably, depending on the nature of the guest molecule, 
the affinity may be higher or lower with increasing DS.186 Moreover, the presence of 
substituents interferes with the carrier performance of drug/CD complexes, as 
demonstrated by Mennini and co-workers.187 The nature of the inclusion is highly 
specific and a proper characterization could shed light on the complex mechanisms 
involved in both CDs complexation and aggregation phenomena. 
The behavior of cholesterol/CD complexes in the presence of glucose, urea and 
inorganic salts has been investigated and does further illustrate the effect of additives on 
aggregation. Cholesterol, solubilized in 1 and 3.3% CD solutions displayed a mixture of 
non-aggregated complexes with diameter of 1-2 nm and aggregated complexes with 
diameter of 100-1000 nm. The effect of additives such as glucose, urea and ionic salts 
on the fraction of aggregated complex did depend on the type of CD. While the additives 
enhanced the fraction of aggregated complexes for random methylated βCD in a 
synergistic way, the opposite effect was noticed in the case of HPβCD where the 
fraction of aggregates also depended on the molar substitution degree.188  
 
Effects of cyclodextrin aggregation on analytical results 
 Numerous analytical techniques are applied to investigate CD and CD complexes,189-194 
but in almost all cases aggregation of CD and CD complexes are not accounted for and 
if existence of such aggregates is acknowledged they are generally referred to as some 
minor event. However, in recent years it has been observed that CD aggregation and 
aggregation of CD complexes can affect analytical results and that the different 
analytical methods do not give consistent results or results that can be explained by the 
conventional thinking of guest/host complex formation.101,102,123 For example, phase-
solubility studies do frequently suggest formation of higher order drug/CD complexes 
with 1:2 or 2:1 stoichiometry although other analytical methodologies such as Job’s plots 
and docking studies clearly show that only 1:1 drug/CD complexes can be formed. 
Likewise, the numerical values of drug/CD formation constants (e.g. K1:1 stability 
constants of 1:1 drug/CD complexes) should be independent of both the drug and CD 
concentration as well as of the method applied to determine their values but frequently 
they are not. Lipophilic compounds that are known to have high affinity for the CD cavity 
should reduce CD solubilization of poorly soluble drugs but sometimes they actually 
enhance the solubilization. Again, these discrepancies and unexpected observations 
can be explained by formation of nano-size drug/CD complex aggregates that are able 
to solubilize poorly soluble drugs through micellar type solubilization. 
The gas phase chemistry involved in MS detection offers the possibility to investigate 
complex formation without the complicating effect of solvent molecules. On the other 
hand, detection of inclusion complexes and/or CD aggregates in gas phase does not 
necessarily reflect the exact situation in solution phase.195,196 A combined approach of 
different analytical techniques will often be required in order to obtain unambiguous 
information on conformation, kinetics and thermodynamics of drug/CDs complexes and 
aggregates in different phases.197,198 
 
Application of CD aggregates as drug delivery systems 
As previously discussed drug/CD complexes self-assemble in aqueous solutions to form 
water-soluble nanoparticles (i.e. aggregates) with a diameter that is frequently a couple 
of hundred nm, and these nanoparticles self-assemble further to form larger aggregates 
(i.e., forming colloidal, opalescent solutions) and microparticulate systems. Aqueous CD 
 solutions containing water-soluble CD complexes and aggregates are equilibrium 
systems where complexes are continuously being formed and dissociated in aqueous 
solutions at rates close to the diffusion-controlled limit (Fig. 9).199 The nanoparticulate 
aggregates are unstable under normal conditions and dissociate almost instantly upon 
media dilution while the microparticular aggregates are somewhat more stable although 
they can dissolve quite rapidly. In fact, CD complexes and their aggregates tend to 
behave more like nanoscale systems, such as nano-suspensions, microemulsions and 
liposomes, rather than true solutions.123,156 Self-assembled CD nanoparticles can have 
the drug delivery properties of nanoparticles but from a regulatory standpoint these 
delivery systems consists of water-soluble CDs that possess the same favorable 
pharmacokinetic and toxicological profile as the CD monomers.200 This unique property 
of CD drug delivery systems has been explored in topical drug delivery to the eye, 
including targeted drug delivery to the eye retina, topical drug delivery to the hair follicles 
and microparticular enhanced drug delivery through mucus.123,139,201,202  
 
Challenges and opportunities 
As recent publications indicate, exploiting nanoaggregate formation has created new 
opportunities in drug delivery.203,204 Although mostly topical formulations have been 
under scrutiny, the use of CD nanoparticles in oral drug delivery could be a promising 
strategy to improve the bioavailability of poorly soluble drugs. However, little is known 
about the behavior of these nanoaggregates under conditions that are representative for 
the gastrointestinal tract. Essential factors that may cause deviations from the 
observations made in pure water include the peculiar intraluminal hydrodynamics and 
the complex and continuously changing composition of the intraluminal environment to 
which the formulation is exposed. Implementation of these biorelevant conditions poses 
some challenges to the evaluation of the performance of the nanoaggregates. 
Upon oral administration, a drug formulation is exposed to a highly dynamic 
environment. Gastric and intestinal contractions generate mixing and propulsion of the 
intestinal contents. Since the forces that are involved in the CD complex aggregation are 
relatively weak, disassembly of the complexes might occur, governed by the 
hydrodynamics existing within the stomach and the small intestine. Messner et al. 
 evidenced a strong decrease in the size of the aggregates upon stirring of an HPβCD 
containing aqueous medium, saturated with hydrocortisone.205 In this set-up, continuous 
stirring was provided by a magnetic bar to demonstrate the relatively weak forces 
needed to induce disaggregation. As the relevance of continuous stirring for the in vivo 
situation is highly questionable, it would, however, be premature to conclude that CD 
nanoaggregates cannot exist in the intraluminal environment.206,207 In the same study, 
Messner et al. also demonstrated a decrease in size of the CD aggregates in function of 
increasing temperatures. Nevertheless, the decrease in total fraction of aggregated 
complexes when comparing 10°C to 36°C was limited.205 Consequently, it appears that 
aggregation can still occur at body temperature.  
A third mechanism which may cause disaggregation is dilution of the formulation as it 
travels through the gastrointestinal tract.208 Recent studies utilizing non-invasive imaging 
techniques or in vivo sampling from stomach and duodenum have generated insight into 
the in vivo behavior of a formulation, including information on the dilution factor upon 
gastrointestinal transit.209-211 Further investigations could provide useful estimates of the 
concentrations of CDs present at different sites along the gastrointestinal tract. 
Clearly, several physiological mechanisms may contribute to disassembly of CD 
nanoaggregates and diminished drug solubilization. It is important to note that this 
decrease in solubilizing capacity does not necessarily have to result in drug 
precipitation, as CDs have shown the ability to stabilize drug supersaturation.156 
Since the introduction of simulated intestinal fluids, intestinal disposition studies have 
been slowly moving away from using aqueous buffers in favor of more biorelevant 
fluids.212 As the pH of these media matches the values measured in stomach and small 
intestine, the ionization of the guest compound (and possibly of the CD molecule) 
becomes relevant. Ionization of the guest compound influences complex formation and 
this has been reported to affect self-assembly.157 Consequently, characterization of CD 
aggregation at different biorelevant pH values is therefore imperative to understand in 
vivo behavior of the CD containing formulation upon oral administration. 
In addition to the effect of pH on ionization, the presence of bile salts and phospholipids 
introduces additional complexity to the evaluation of CD self-assembly. It has been 
shown that both bile salts and phospholipids can act as guest molecules in CD 
 complexes213-215 As mentioned earlier in this review, in multicomponent systems, 
competition between different guest molecules may result in reorganization of 
complexes and in dynamic systems, such as the intestinal environment, complex 
composition (and, consequently, CD aggregation) can change over time. As a result, the 
aggregation behavior and overall performance of the formulation in biorelevant media 
and in pure water may strongly differ. Therefore, the road towards the application of CD 
nanoparticles as a formulation strategy for oral drug delivery would have to include a 
thorough understanding of the behavior of CDs in biorelevant media.  
A number of analytical tools are already in place to characterize drug-CD complexes and 
their aggregates. Somewhat surprisingly, so far MS has not been used for the 
characterization of CD aggregates. Over the last decade MS has developed into a key 
technique for the analysis of biomacromolecules, including proteins and their complexes. 
Ionization techniques allowing transfer of intact macromolecular assemblies into the gas 
phase have been established.216 Based on the ongoing advances in resolution and 
sensitivity,217 we expect MS to develop into a viable technique for the analysis of CD 
assemblies. 
As compared to characterization in water, optimizing the methods for application in more 
complex media may prove to be challenging. Interaction between the CDs and 
constituents of the biorelevant media may impede the interpretation of analytical tests. 
Moreover, with respect to visualization, both colloidal structures consisting of bile salts 
and lipids and the CD aggregates have been reported to take different shapes, spanning 
overlapping size ranges. Obviously, this could hamper the interpretation of microscopic 
images, for example.  
Further development and optimization of analytical methods can provide reliable 
information on the CD aggregation phenomenon under different biorelevant conditions. 
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Figure 1. A: Simple amphiphiles such as fatty acids and alcohols form micelles in aqueous solutions. 
The micelles have a lipophilic core and a hydrophilic surface. Formation of micelles minimizes the 
contact surface between water molecules and the non-polar group of an amphiphile with a 
consequent decrease in free energy. B: Hydrophobic drugs such as steroids do also self-assemble in 
aqueous solutions to form dimers, trimers and higher order oligomers to reduce their contact surface 
with water.218 
 
Figure 2. A fragment of hydrogen bond network of liquid water. Hydrogen bonds marked by black 
dotted line. 
 
Figure 3. Number of water molecules in the hydration shell of glucose molecules that are shared with 
a second solute molecule. Based on work Fioretto et al.36 
 
Figure 4. The effect of solute concentration on the viscosity of pure aqueous 2-hydroxypropyl-β-CD 
(HPβCD) and glucose solutions. Based on219 and data from Nordic Sugar A/S, Denmark 
(www.nordicsugar.com). 
 
Figure 5. Normalized mean trehalose cluster size for at different trehalose concentration in pure 
water where ntre corresponds to the weighted average number of trehalose molecules in a given 
cluster and Ntre to the total number of trehalose molecules in a given system. Based on molecular 
dynamic simulations.54 
 
Figure 6. An average size of native CD aggregates (n is the number of molecules) versus CD 
concentration observed by light scattering taken from literature. Reprinted from105. 
 
Figure 7. Schematic representation of the packing of CD molecules in the cage (a) and channel (b) 
crystal structures. 
 
Figure 8. Schematic representation of a drug-CD system in aqueous solution. 
 
Figure 9. Formation of complex aggregates in aqueous solution. 
 
Table 1. Structure and physicochemical properties of the natural αCD, βCD, and γCD and some of their derivatives. 
 
Properties αCD βCD HPβCD SBEβCD RMβCD γCD HPγCD 











Molar substitution: - - 0.65 0.9 1.8 - 0.6 
Molecular weight of anhydrous 
compound (Da): 
972.8 1135 1400 2163 1312 1297 1576 
Calculated LogP(octanol/water) at 25°C:a -13 -14 -11 < -10 -6 -17 -16 
Approx. solubility in water at 25°C 
(mg/ml):a, b 
130 18.4 > 600 > 500 > 600 250 > 600 
Number of H-donors: 18 21 21 15 8 24 24 
Number of H-acceptors: 30 35 39 53 35 40 45 
a From SciFinder, ACS, USA (scifinder.cas.org). 
b From work of Sabadini et al.220
Table 2. Formation and stability of CD aggregates in aqueous solutions. 
Property  
The natural CDs The natural αCD, βCD and γCD do form aggregates by themselves in 
pure aqueous CD solutions but the aggregation is very low with 
much less than 1 % of dissolved CD present in the form of 
aggregates. 
Formation of inclusion 
complexes 
Formation of drug/CD inclusion complexes increases the 
aggregation, both in the case of the natural CDs and in the case of 
the randomly substituted CD derivatives. 
The aggregate diameter The diameter of the complex aggregates depends on the drug/CD 
properties as well as the concentration of drug/CD inclusion 
complexes, increasing with increasing availability of drug/CD 
complexes. 
The degree of 
aggregation 
The degree of aggregation depends on the availability of drug/CD 
complexes in the aqueous solution, increasing with increasing 
availability of drug/CD complexes.  
Effects of organic 
solvents and temperature 
Addition of organic solvents such as ethanol that are known to 
decrease the complexation will reduce the aggregation. Also, 
heating of aqueous CD solutions will result in decreased 
aggregation. 
Dynamic equilibrium In aqueous solutions drug/CD complex aggregates are in dynamic 
equilibrium with un-aggregated (i.e., free) complexes. Aggregates 
are constantly being formed and dissembled. 
The aggregates are 
unstable 
The complex aggregates are unstable and dissemble up on media 
dilution. 
Limited solubility Complexes of the natural αCD, βCD and γCD have limited solubility 
in water and tend to precipitate in aqueous solutions as solid 
drug/CD complex aggregates. Their complexes are frequently less 
soluble than the CDs themselves. 
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